Literature DB >> 21845810

Passive smoking and respiratory allergies in adolescents.

A Mlinaric1, S Popovic Grle, S Nadalin, B Skurla, H Munivrana, M Milosevic.   

Abstract

OBJECTIVE: The aim of our study was to investigate impact of active and passive smoking on total and specific serum IgE levels and on incidence of developing allergic diseases (i.e. asthma, rhinitis) in a group of Croatian adolescents.
METHODS: Our study consisted of random sample of one hundred fifty-five (155) voluntary pupils (80 males and 75 females), with mean age of 16.72 +/- 1.25 years, from one high school in the city of Varazdin (north-west part of Croatia). Their smoking habits were examined by interview administered by a single trained survey worker while diagnosis of allergic disease (i.e. asthma and allergic rhinits) had to be previously confirmed by physician. Total and specific serum IgE levels were determined using enzyme-linked immunosorbent assay (ELISA) method in Central Laboratory of Clinic for lung diseases Jordanovac, Zagreb (Croatia).
RESULTS: Statistically significant higher prevalence of allergic diseases was found in the group of passive smokers as opposed to nonsmokers (chi2=9.29, p=0.002) as well as in active smokers compared to nonsmokers (chi2=4.45, p=0.034). Also, total IgE (IU/ml) was significantly higher in passive smokers when compared to non-smokers (t=13.039, p<0.01), and in passive smokers as opposed to active smokers as well (t=4.960, p<0.01), while difference in its level between active smokers and non-smokers was not statistically significant. The level of specific IgE to Dermatophagoides pteronyssinus between active smokers, passive smokers and non-smokers resulted to be not statistically significant.
CONCLUSIONS: Results of the study indicate that clinical manifestations of allergic diseases are more frequent in smokers (both active and passive) than in nonsmokers. Our investigation leads us to a presumption of a possibly more harmful effect of passive than active smoking in the adolescent high school population. Statistically highest IgE level in passive smokers as opposed to non-smokers or smokers could be attributed to longer duration of exposure to tobacco smoke in passive smokers and tobacco's potential cumulative effect on allergic senzitisa-tion, although investigations with more precised and detailed mesures including higher number of participants are warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845810

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Trends in smoking initiation in Europe over 40 years: A retrospective cohort study.

Authors:  Alessandro Marcon; Giancarlo Pesce; Lucia Calciano; Valeria Bellisario; Shyamali C Dharmage; Judith Garcia-Aymerich; Thorarinn Gislasson; Joachim Heinrich; Mathias Holm; Christer Janson; Deborah Jarvis; Bénédicte Leynaert; Melanie C Matheson; Pietro Pirina; Cecilie Svanes; Simona Villani; Torsten Zuberbier; Cosetta Minelli; Simone Accordini
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

2.  Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers.

Authors:  Calogero Grillo; Ignazio La Mantia; Caterina M Grillo; Giorgio Ciprandi; Martina Ragusa; Claudio Andaloro
Journal:  Acta Biomed       Date:  2019-07-10

3.  Prevalence of Cigarette Smoking among Professionally Active Adult Population in Poland and Its Strong Relationship with Cardiovascular Co-Morbidities-POL-O-CARIA 2021 Study.

Authors:  Anna Rulkiewicz; Iwona Pilchowska; Wojciech Lisik; Piotr Pruszczyk; Justyna Domienik-Karłowicz
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

4.  Secondhand smoke in combination with ambient air pollution exposure is associated with increasedx CpG methylation and decreased expression of IFN-γ in T effector cells and Foxp3 in T regulatory cells in children.

Authors:  Arunima Kohli; Marco A Garcia; Rachel L Miller; Christina Maher; Olivier Humblet; S Katharine Hammond; Kari Nadeau
Journal:  Clin Epigenetics       Date:  2012-09-25       Impact factor: 6.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.